搜索
Jade Biosciences Ord Shs
JBIO添加自选
23.355USD
-0.775-3.21%
收盘 05/15, 16:00（美东）报价延迟15分钟
1.15B总市值
亏损市盈率 TTM
关于 公司
Jade Biosciences Ord Shs简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Jade Biosciences Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
37.81K
--
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+8.51%
Mr. Timothy P. Noyes
Mr. Timothy P. Noyes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Stephen K. Yu
Mr. Stephen K. Yu
Senior Vice President - Quality
Senior Vice President - Quality
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
37.81K
--
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+8.51%
Mr. Timothy P. Noyes
Mr. Timothy P. Noyes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
13.72%
Fairmount Funds Management LLC
9.23%
RA Capital Management, LP
7.44%
VR Adviser, LLC
6.52%
Bellevue Asset Management AG
6.51%
其他
56.59%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
13.72%
Fairmount Funds Management LLC
9.23%
RA Capital Management, LP
7.44%
VR Adviser, LLC
6.52%
Bellevue Asset Management AG
6.51%
其他
56.59%
股东类型
持股股东
占比
Investment Advisor
35.36%
Hedge Fund
24.74%
Venture Capital
20.09%
Investment Advisor/Hedge Fund
20.04%
Individual Investor
1.12%
Private Equity
1.08%
Research Firm
0.32%
Bank and Trust
0.14%
Insurance Company
0.02%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
161
38.26M
85.14%
--
2026Q1
243
52.32M
106.02%
+8.39M
2025Q4
225
39.61M
80.33%
+327.27K
2025Q3
219
31.65M
77.53%
-1.17M
2025Q2
222
32.33M
102.43%
+21.99M
2025Q1
207
926.72K
111.95%
-347.50K
2024Q4
207
879.69K
106.31%
-203.28K
2024Q3
202
808.07K
98.05%
-248.23K
2024Q2
199
794.81K
96.63%
-106.00K
2024Q1
171
831.84K
104.51%
-50.52K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
6.77M
13.73%
+1.98M
+41.35%
Dec 31, 2025
Fairmount Funds Management LLC
4.55M
9.23%
--
--
Dec 31, 2025
RA Capital Management, LP
3.67M
7.44%
+456.11K
+14.19%
Dec 31, 2025
VR Adviser, LLC
3.22M
6.53%
--
--
Dec 31, 2025
Bellevue Asset Management AG
3.34M
6.77%
+3.34M
--
Dec 31, 2025
Janus Henderson Investors
3.06M
6.21%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.60M
5.26%
+634.54K
+32.35%
Dec 31, 2025
Baker Bros. Advisors LP
1.64M
3.33%
+1.64M
--
Dec 31, 2025
Remedium Capital Partners, LLC
1.58M
3.2%
+1.58M
--
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月9日 周二
更新时间: 12月9日 周二
机构名称
占比
iShares Micro-Cap ETF
0.08%
iShares Russell 2000 Value ETF
0.03%
Global X Russell 2000 ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 3000 ETF
0%
iShares Russell 2000 Growth ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.08%
iShares Russell 2000 Value ETF
占比0.03%
Global X Russell 2000 ETF
占比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
iShares Russell 3000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Apr 21, 2025
Merger
35→1
公告日期
除权除息日
类型
比率
Apr 21, 2025
Merger
35→1
